drugset / Trial / NCT00905762

Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation

NCT00905762

Phase 1 Completed 119 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupDouble-blindScreening

Summary

The purpose of this study is to assess the concentration of besifloxacin compared to gatifloxacin and moxifloxacin in human conjunctival tissue, following a single drop of the drug instilled topically into the study eye. Conjunctival biopsies will be performed at specified time points, followed by the use of loteprednol etabonate/tobramycin ophthalmic suspension four times a day for 5 days.

Timeline

Start
2009-03
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Besifloxacin Small molecule 0.6 % Topical
Comparator Gatifloxacin Small molecule 0.3 % Topical
Comparator Moxifloxacin Small molecule 0.5 % Topical

Indications

No indication recorded.